The effects of organ dysfunction on drug dosing.
Egorin
Merrill
M
University of Pittsburgh Cancer Institute, USA.
D000970:Antineoplastic Agents / Q000493:pharmacokinetics*; D001711:Biotransformation; D002986:Clinical Trials as Topic; D004305:Dose-Response Relationship, Drug; D017277:Drug Approval; D006801:Humans; D007674:Kidney Diseases / Q000378:metabolism*; D008107:Liver Diseases / Q000378:metabolism*; D009369:Neoplasms / Q000188:drug therapy
D000970:Antineoplastic Agents